Accès à distance ? S'identifier sur le proxy UCLouvain
Clinical studies, the interests and limits of using dabigatran in atrial fibrillation
Primary tabs
- Open access
- 221.60 K
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2012 |
Language | Français |
Journal information | "Journal de Pharmacie de Belgique" - no. 1, p. 8-17 (2012) |
Peer reviewed | yes |
Publisher | Algemene Pharmaceutische Bond |
issn | 0047-2166 |
Publication status | Publié |
Affiliations |
UCL
- (MGD) Laboratoire de biologie clinique UCL - (MGD) Service d'hématologie UCL - (MGD) Département de pharmacie UCL - SSS/IREC/MONT - Pôle Mont Godinne UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - SSS/LDRI - Louvain Drug Research Institute |
MESH Subject | Aged ; Female ; Humans ; Male ; Monitoring, Physiologic ; Platelet Aggregation ; Stroke ; Thromboembolism ; Warfarin ; beta-Alanine ; Anti-Arrhythmia Agents ; Anticoagulants ; Antidotes ; Atrial Fibrillation ; Benzimidazoles ; Clinical Trials as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic |
Links |
Bibliographic reference | Sternotte, Anthony ; Douxfils, J ; Chatelain, Bernard ; Chatelain, Christian ; Mullier, François ; et. al. Clinical studies, the interests and limits of using dabigatran in atrial fibrillation. In: Journal de Pharmacie de Belgique, no. 1, p. 8-17 (2012) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/124490 |